Rep. Elijah Cummings, D-Md., the likely next head of the House Oversight Committee, wants to bring the CEOs of drugmakers to grill them on the actual cause behind high drug prices.
Cummings said he wants CEOs to explain their funding for research and development. Pharma companies often employ a defense that high prices are justified to compensate for high research and development costs.
